# A Study of S6G5T-3 in the Treatment of Acne Vulgaris

> **NCT03761784** · PHASE3 · COMPLETED · sponsor: **Sol-Gel Technologies, Ltd.** · enrollment: 424 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** S6G5T-3
- **DRUG:** S6G5T-8

## Key facts

- **NCT ID:** NCT03761784
- **Lead sponsor:** Sol-Gel Technologies, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-21
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 424 (ACTUAL)
- **Last updated:** 2021-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03761784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03761784, "A Study of S6G5T-3 in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03761784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*